Infertility Market: Declining Global Fertility Rates Fueling Demand for Assisted Reproductive Technology and Surgeries
The Infertility Market is expanding rapidly, with the global treatment market valued at $1.5 billion in 2021 and projected to reach $2.2 billion by 2026 with a CAGR of 8.1%. The single largest driver is the declining global fertility rate, primarily influenced by the trend of people postponing marriage and childbearing, leading to increased age-related infertility. This demographic shift is creating a massive demand for diagnostic and therapeutic services. The market is segmented into various products and procedures, with Assisted Reproductive Technology (ART), including In Vitro Fertilization (IVF), capturing the largest share of procedures. The increasing success rates of ART and its growing global acceptance are key factors propelling this segment.
The market encompasses an array of products, with the equipment segment—including microscopes, incubators, and micromanipulator systems—expected to witness the highest growth, driven by continuous technological advancements. Female infertility treatment also commands the largest segment by patient type, reflecting the higher availability of treatment options and the growing number of specialized fertility centers. While high procedural costs and unsupportive reimbursement policies in some developed markets present a restraint, emerging markets such as China and India offer significant growth opportunities, often through the channel of medical tourism. The future market trajectory will be shaped by further innovations in genetic testing, embryo screening, and the global regulatory framework surrounding fertility procedures.